The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2023. The authors of the following 6 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
The National Home Infusion Foundation (NHIF) is proud to announce that Janice Elliott, BS, RN, CRNI®, VA-BC is the recipient of the 2023 Lynn Giglione Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce its 2023-2024 Board of Directors. Beginning this term, the association expanded to 15 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations. Board members serve 3-year terms as representatives for their NHIA member organization.
The National Home Infusion Association (NHIA) is proud to announce that John Rademacher, MBA, CEO of Option Care Health has been named Chair of its Board of Directors.
The data supports NHIA’s assessment that the benefit—as currently implemented—continues to flail and lacks sufficient participation from providers to ensure equitable access to beneficiaries across the U.S. This is the second report by CMS illustrating the failure of the Part B HIT services benefit to attract providers.
The National Home Infusion Foundation (NHIF) invites all specialty infusion providers to participate in a new research study involving pharmacists collecting time data on professional services related to specialty drug patient care.
The National Home Infusion Association (NHIA) is proud to announce that Penny Allen, RD, CNSC, FASPEN, FNHIA is the recipient of the 2023 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) has prepared a white paper summarizing the impact of cost increases incurred by infusion providers due to pandemic-related supply shortages with a particular focus on parenteral nutrition (PN) components and disposable supplies. NHIA found that prices for PN components and disposable items rose dramatically during the pandemic due to supply chain challenges and shortages.
NHIA responded to a CMS request for information on the modification of essential health benefits (EHB) required to be covered by Accountable Care Organization (ACO) plans.
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to reduce administrative burden and remove barriers to accessing certain infusion services.
The National Home Infusion Association (NHIA) is pleased to announce the 2023 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
NHIA President & CEO Connie Sullivan responds to recent alarmist news stories based on flawed research about CLABSI surveillance in home infusion.
“Misleading stories about the risks of home infusion have real consequences and may result in fewer patients eventually having access to these essential services.”
NHIA is disappointed by the characterization of a recent study regarding infection control in home infusion, which the association asserts is not at all reflective of home infusion therapy standards and practices.
On December 2, 2022, NHIA sent a follow-up letter to Defense Health Agency, including a copy to Express Scripts (ESI), sharing recent updates on efforts by ESI to narrow the TRICARE pharmacy network and urging the DOD to reinstate all home infusion providers to the ESI network to prevent disruptions in home infusion access for TRICARE beneficiaries.
NHIA’s Clinical Program Manager Michelle Simpson, PharmD, BCSCP, MWC presented research conducted by the National Home Infusion Foundation (NHIF) at ID Week, the meeting of the Infectious Diseases Society of America (IDSA) held October 19-23 in Washington, D.C.
A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) and increase access to home infusion therapy for Medicare beneficiaries.
Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
Eliminating the inequities in how people access and receive health care can go a long way toward improving health care delivery, outcomes, and population health, according to Christina Ritchey from Optum Infusion Pharmacy. Equity in health care means the state in which everyone has a fair and just opportunity to attain their highest level of health.
Attendees gathered for a morning coffee break after an engaging breakfast symposium from IgNS on PANS/PANDAS in Children. The beautiful backdrop overlooking the Potomac played host to some excellent conversations among professionals as everyone fueled up for a jam-packed day of education.
As we enter the third year since the global pandemic and a return to “normal,” you might expect that trauma and anxiety related to the crisis would be waning. In fact, the opposite is true, according to Alissa Putman, PhD with Johns Hopkins Community Physicians. In 2022, 65% of psychologists reported an increase in symptom severity, including stress, anxiety, and depression. All of which can affect health care’s most precious resource: its workers.
With record attendance and beautiful spring weather in D.C., we had a full first day of action at NHIA 2023, starting off early with our three preconference seminars: Executive, Sterile Compounding and Revenue Cycle, covering valuable information for professionals in a variety of roles.
The National Home Infusion Association has announced the finalists for its 2023 Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
The National Home Infusion Association (NHIA) is pleased to announce that it successfully petitioned the Centers for Medicare and Medicaid Services (CMS) to secure a new billing code for injectable immunotherapies and revise an existing code to facilitate administration of a wider range of monoclonal antibodies for Respiratory Syncytial Virus (RSV).
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2023. The authors of the following 6 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
The National Home Infusion Foundation (NHIF) is proud to announce that Janice Elliott, BS, RN, CRNI®, VA-BC is the recipient of the 2023 Lynn Giglione Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce its 2023-2024 Board of Directors. Beginning this term, the association expanded to 15 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations. Board members serve 3-year terms as representatives for their NHIA member organization.
The National Home Infusion Association (NHIA) is proud to announce that John Rademacher, MBA, CEO of Option Care Health has been named Chair of its Board of Directors.
The data supports NHIA’s assessment that the benefit—as currently implemented—continues to flail and lacks sufficient participation from providers to ensure equitable access to beneficiaries across the U.S. This is the second report by CMS illustrating the failure of the Part B HIT services benefit to attract providers.
The National Home Infusion Foundation (NHIF) invites all specialty infusion providers to participate in a new research study involving pharmacists collecting time data on professional services related to specialty drug patient care.
The National Home Infusion Association (NHIA) is proud to announce that Penny Allen, RD, CNSC, FASPEN, FNHIA is the recipient of the 2023 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) has prepared a white paper summarizing the impact of cost increases incurred by infusion providers due to pandemic-related supply shortages with a particular focus on parenteral nutrition (PN) components and disposable supplies. NHIA found that prices for PN components and disposable items rose dramatically during the pandemic due to supply chain challenges and shortages.
NHIA responded to a CMS request for information on the modification of essential health benefits (EHB) required to be covered by Accountable Care Organization (ACO) plans.
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to reduce administrative burden and remove barriers to accessing certain infusion services.
The National Home Infusion Association (NHIA) is pleased to announce the 2023 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
